A New Look, New Direction for Society of Nuclear Medicine

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 8
Volume 11
Issue 8

LOS ANGELES-The Society of Nuclear Medicine (SNM) has changed its logo for the first time in its 49-year history. The new logo is designed to create a bright, fresh look for SNM, Alan Maurer, MD, said at the Society’s 49th Annual Meeting. Dr. Maurer, director of nuclear medicine, Temple University, is the immediate past president of the SNM.

LOS ANGELES—The Society of Nuclear Medicine (SNM) has changed its logo forthe first time in its 49-year history. The new logo is designed to create abright, fresh look for SNM, Alan Maurer, MD, said at the Society’s 49th AnnualMeeting. Dr. Maurer, director of nuclear medicine, Temple University, is theimmediate past president of the SNM.

The new logo retains the roots and heritage of SNM by keeping the atomic orbital symbol. A tagline in the new logo, "advancing molecular imaging," is seen emerging from the atomic orbital. It replaces the caduceus holding the atomic orbital in the old logo.

Although molecular imaging has always been an important part of nuclear medicine, the new tagline identifies the organization as being on the cutting edge of molecular imaging technology, said Michael Gelfand, MD, the new SNM president. "The new logo represents a first step in creating a new and evolving identity for SNM," he said. 

Recent Videos
According to Jorge Nieva, MD, there are a multitude of things that can be explored to enhance the treatment landscape for lung cancer.
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
Related Content